 |
 |
including one from our very own nick! :) ----- Original Message ----- From: "Kathleen Cochran" <[log in to unmask]> To: <[log in to unmask]> Sent: Sunday, July 17, 2016 10:51 PM Subject: MJFF onto Tasigna > Here is a link to an article on nilotinib/Tasigna dated March 2016; quite > a > few comments are included. > > <http://goog_179384043> > http://www.mdnews.com/news/2016_03/drug-repurposing-yields-hope-for-reversing-effects-of-parkinsons.aspx > > Kathleen > > > > On 17 July 2016 at 07:37, Kathleen Cochran <[log in to unmask] > <javascript:_e(%7B%7D,'cvml',[log in to unmask]);>> wrote: > >> Hi Ray, >> >> I'm pretty sure that the slides from the presentation will be posted on >> the MJFF website. I will share related links. >> >> >> On Sunday, July 17, 2016, Rayilyn Brown <[log in to unmask] >> <javascript:_e(%7B%7D,'cvml',[log in to unmask]);>> wrote: >> >>> hope u will report on this, I registered but don't know how to access >>> it >>> thanks >>> >>> -----Original Message----- From: Kathleen Cochran >>> Sent: Wednesday, July 13, 2016 7:07 PM >>> To: [log in to unmask] >>> Subject: Re: MJFF onto Tasigna >>> >>> Thanks, Ray! >>> >>> Here's a link to a registration form for the MJFF webinar. There's space >>> for registrants to submit questions in advance of the event. >>> >>> A big question for me is affordability of nilotinib. What good will it >>> be >>> if it's priced out of reach for most of us? >>> >>> I'd be curious to know what questions/comments others have. >>> >>> >>> https://www.michaeljfox.org/understanding-parkinsons/webinar-registration.php?id=11&e=1224270&k=2CCA24B7E83A23999FBC4B1376C4F944 >>> >>> On Tuesday, July 12, 2016, Rayilyn Brown <[log in to unmask]> wrote: >>> >>> we have to wait until 2017 >>>> >>>> >>>> >>>> https://www.michaeljfox.org/foundation/news-detail.php?nilotinib-update-where-we-stand-with-cancer-drug-for-parkinson&et_cid=610090&et_rid=61638552&et_lid=Read+Moreem_cid= >>>> >>>> Ray >>>> Rayilyn Brown >>>> Past Director AZNPF >>>> Arizona Chapter National Parkinson Foundation >>>> >>>> ---------------------------------------------------------------------- >>>> To sign-off Parkinsn send a message to: mailto: >>>> [log in to unmask] >>>> In the body of the message put: signoff parkinsn >>>> >>>> >>> ---------------------------------------------------------------------- >>> To sign-off Parkinsn send a message to: mailto: >>> [log in to unmask] >>> In the body of the message put: signoff parkinsn >>> >> > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn